Prescription Required
Inclusive of all taxes
In Treatment of Bacterial infections Lyforan Plus 1000 mg/500 mg Injection is used to treat bacterial infections like pneumonia, bronchitis, gonorrhea, meningitis, and severe infections of the kidney, urinary system, bones, joints, and skin. It may also be used before surgery, and during and after a cesarean section, in order to prevent the patient from getting an infection. It stops the growth of bacteria causing infection. This further reduces the discomforts associated with various infections and helps in early recovery.
Caution is advised when consuming alcohol with Lyforan Plus 1000 mg/500 mg Injection. Please consult your doctor.
Lyforan Plus 1000 mg/500 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Lyforan Plus 1000 mg/500 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Lyforan Plus 1000 mg/500 mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Lyforan Plus 1000 mg/500 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Lyforan Plus 1000 mg/500 mg Injection may be needed. Please consult your doctor. Regular monitoring of kidney function may be advised while you are taking this medicine.
There is limited information available on the use of Lyforan Plus 1000 mg/500 mg Injection in patients with liver disease. Please consult your doctor.
If you miss a dose of Lyforan Plus 1000 mg/500 mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Ancalima Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tablets India Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pushkar Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jpee Drugs || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: East African (India) Overseas || ₹14.5/tablet (25% cheaper)